{
  "image_filename": "table_p7_det_6_000.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p7_det_6_000.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_000",
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "supports_claim": false,
  "explanation": "A table titled \u201cAvailable 2022\u201323 influenza vaccines\u201d listing vaccine types (egg-based IIV4s and LAIV4, ccIIV4, RIV4) against scenarios of previous severe allergic reactions (e.g., anaphylaxis). The cells indicate \u2018Contraindication\u2019 or \u2018Precaution\u2019 for each combination of vaccine type and allergy history. does not support the claim because the table addresses allergic reaction contraindications and precautions for different vaccine platforms rather than presenting any data on antibody responses or cross-reactivity induced by recombinant HA antigens versus egg-derived vaccines.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table titled \u201cAvailable 2022\u201323 influenza vaccines\u201d listing vaccine types (egg-based IIV4s and LAIV4, ccIIV4, RIV4) against scenarios of previous severe allergic reactions (e.g., anaphylaxis). The cells indicate \u2018Contraindication\u2019 or \u2018Precaution\u2019 for each combination of vaccine type and allergy history.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table addresses allergic reaction contraindications and precautions for different vaccine platforms rather than presenting any data on antibody responses or cross-reactivity induced by recombinant HA antigens versus egg-derived vaccines.",
    "confidence_notes": null
  }
}